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Introduction
In New York City (NYC), pandemic influenza A H1N1 was first identified in April 2009 and 
was considered to have community-wide transmission by the middle of May 2009 [1-3]. 
According to the Centers for Disease Control and Prevention (CDC), H1N1 presented with 
symptoms similar to seasonal influenza with the majority of patients reporting fever, cough, 
or shortness of breath [4]. Prior seasonal influenza vaccines, including the 2009 preparation, 
offered no protection against H1N1, suggesting widespread illness susceptibility [5].
The 2009 H1N1 influenza vaccine was licensed on September 15, 2009 and became 
available two weeks later [6, 7]. One dose of the H1N1 vaccination provided an adequate 
immune response, with protection rates for adults ranging from 93% to 100% [8]. Health 
care and emergency medical service (EMS) workers were among the first groups 
recommended for H1N1 vaccination [6], which included Fire Department of New York City 
(FDNY) firefighters and EMS workers.
In prior years, acceptance rates of seasonal influenza vaccinations have been reported to 
range from 10 to 62% in hospital personnel [9-11], and from 40% in healthy adults working 
at a university [12] to almost 100% in the US military, where vaccination has been 
mandatory since 1954 [13-15]. At FDNY, acceptance rates of seasonal influenza vaccine 
have averaged around 50% (unpublished data). Acceptance rates vary widely based, in part, 
on the population studied, and their perception of the vaccine's safety, efficacy, and benefit 
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[9, 11, 16]. Among healthcare workers (HCWs), predictors of seasonal influenza vaccination 
acceptance include prior vaccination, older age, longer tenure as a HCW, and a vaccine 
awareness campaign with vaccine-related education and easy access to no-cost, on-site 
vaccination during work hours [9-11].
Influenza vaccination is offered to HCWs in the belief that it will reduce influenza-like 
illness (ILI)-related absenteeism and nosocomial infection [11]. Several studies in HCWs 
have found that seasonal influenza vaccination did reduce the incidence of ILI-related sick 
leave, but results were mixed on whether there were significant reductions in the duration of 
ILI-related sick leave [17, 18].
Determining predictors of acceptance of a new vaccine is especially important for HCWs – a 
population that could be severely limited by ILI-related sick leave during a pandemic. Prior 
to the H1N1 vaccine's availability, a survey of workers’ intention to receive the H1N1 
vaccination found that prior acceptance of seasonal influenza vaccination was a strong 
predictor of intention to accept H1N1 vaccine [19].
The purpose of the current study was to determine predictors of H1N1 vaccine acceptance in 
nearly 14,000 FDNY firefighters and EMS workers during the 2009-2010 influenza season 
and to assess whether removing potential barriers for voluntary vaccine acceptance through 
a dedicated campaign would result in higher vaccine acceptance rates and a reduction in ILI-
related sick-leave. We also assessed whether these outcomes differed in a smaller group of 
FDNY workers with co-morbid pulmonary disease.
Methods
Since the early 1990's the FDNY Bureau of Health Services (BHS) has offered a voluntary 
seasonal influenza vaccination program at no-cost to all FDNY firefighters and EMS 
workers during regularly scheduled medical monitoring and treatment visits to BHS. After 
9/11/01, FDNY developed a bio-preparedness drill, which was designed to practice rapid 
distribution of medications to the workforce in the event of a biological disaster. During this 
drill, Fire and EMS units are dispatched to an FDNY-BIOPOD (biologic points of 
distribution) site within NYC during their usual work shift. Since 2005, BHS has used this 
annual, city wide, one-day drill to provide seasonal influenza vaccine to firefighters and 
EMS workers at each of the designated BIOPOD sites. Prior to the FDNY-BIOPOD drill, 
participants are educated regarding vaccine benefit, risk, and efficacy through a dedicated 
newsletter, department briefings, and union meetings. This information is repeated during 
the FDNY-BIOPOD. In 2009, BHS expanded FDNY-BIOPOD to a four-day drill in an 
attempt to maximize the number of workers offered the H1N1 vaccination instead of the 
seasonal influenza vaccine. As in prior years, all dispatched units were required to 
participate, but vaccination remained voluntary. Refusals and acceptances were documented 
in the electronic medical record immunization table. We compared H1N1 vaccine offers and 
acceptance rates during the FDNY-BIOPOD to H1N1 vaccine offers and acceptance rates 
during BHS regularly scheduled visits for annual medical monitoring and treatment. We also 
compared H1N1 vaccination rates during 2009 FDNY-BIOPOD to acceptance rates of 
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seasonal influenza vaccinations during other FDNY-BIOPOD years (2005-2008 and 2010). 
Seasonal influenza vaccination was not offered during 2009 FDNY-BIOPOD.
Study Participants
During the 2009 influenza season, FDNY employed 14,141 firefighters and EMS workers. 
We examined the FDNY electronic medical database for documentation that the 2009 H1N1 
vaccine was offered, the offer date, and whether the vaccine was accepted or refused. After 
excluding 137 workers with vaccination contraindications, the final study population 
consisted of 14,004 active FDNY workers. Documentation of prior influenza vaccinations at 
FDNY were obtained from the electronic medical database. Age, gender, race, and service 
(firefighter or EMS) were obtained from the FDNY employee database. Smoking status was 
obtained from self-administered questionnaires.
ILI Sick Leave
In an effort to reduce the spread of ILI during the H1N1 pandemic, ILI sick leave was 
considered work-related. To qualify for paid-sick leave and free medication, FDNY required 
evaluation by an FDNY physician, with the diagnosis documented in the FDNY electronic 
medical record. To analyze ILI-related sick leave we considered diagnoses of bronchitis, 
upper respiratory tract infection (URI), or influenza that occurred from 5/1/2009 through 
6/15/2010, as being potentially H1N1 related. We selected these diagnoses from 438 
diagnoses in the FDNY database for their consistency with CDC data for ILI in the United 
States. We also performed a validation analysis within the FDNY database demonstrating 
that these three diagnoses were the most likely to increase during the 2009 ILI season. 
Because it takes 1-2 weeks for H1N1 vaccination to confer immunity [20], sick leave was 
analyzed if it occurred at least 14 days post-vaccination.
Co-morbid Respiratory Disease or Dysfunction
To examine whether those with pre-existing respiratory disease, a risk factor for influenza-
related pneumonia and death, were more likely to accept H1N1 vaccination, we constructed 
a group using two or more visits to an FDNY pulmonologist since 2007 as a proxy measure 
of co-morbid respiratory disease. We then compared data on vaccine acceptance rates in the 
co-morbid group to those in the group without co-morbid respiratory disease during the 
same period.
We also determined whether the level of pulmonary function, independent of co-morbid 
respiratory disease, influenced one's decision to accept H1N1 vaccination. Spirometry data 
were obtained from the most recent annual medical evaluation available in the electronic 
medical database. Forced expiratory volume (FEV1) percent predicted was calculated using 
NHANES III equations based on age at examination, height, gender, and race/ethnicity [21].
Statistical Analyses
We analyzed demographic and other variables in relation to documented offers of H1N1 
vaccine (yes/no) and acceptance of vaccination when offered. We present means and 
standard deviations (SD) of continuous variables. Bivariate analyses of categorical variables 
used χ2 with odds ratios (OR) and 95% confidence intervals (CI95). We tested the following 
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as independent predictors of vaccine acceptance: vaccination at FDNY-BIOPOD, having an 
FEV1 ≤ 80% predicted, and having a co-morbid respiratory disease, after adjustment for 
age, gender, race, service (firefighters or EMS), rank (officer or non-officer), smoking status, 
and prior seasonal influenza vaccination acceptance. We constructed separate multivariable 
logistic regression models to test whether H1N1 vaccine acceptance and service were 
statistically significant predictors of sick leave. All analyses were performed using Statistical 
Analysis Software, version 9.2 (SAS Institute, Cary, N.C.).
Results
The H1N1 influenza vaccine was offered to 10,612 active-duty FDNY workers (8,358 
firefighters and 2,254 EMS workers) or 76.6% of the active workforce (table 1). This 
included 9,559 at the FDNY-BIOPOD (11/5/2009 – 11/8/2009) and 1,053 at BHS visits for 
medical monitoring/treatment evaluations between 10/1/2009 to 4/2/2010 (table 1). Of the 
N=3,392 not offered vaccination, 784 were not available (mostly due to leave) during 
FDNY-BIOPOD. The remaining 2,608 active FDNY workers had no record of an H1N1 
vaccination offer. However, there were no statistically significant differences in age, gender, 
smoking status, rank, or having received previous seasonal influenza vaccinations between 
those with no record of H1N1 vaccination offer (N=2,608) compared with those offered 
H1N1 vaccination (N=10,612).
The acceptance rate among those offered the vaccine was 57.2% (5,469/9,559) during 
FDNY-BIOPOD as compared to only 34.4% (362/1053) during medical visits to BHS 
(p=<0.0001) for an overall acceptance rate of 55.0%. The H1N1 vaccination acceptance rate 
of 57.2% at FDNY-BIOPOD was higher than in prior FDNY-BIOPOD seasonal influenza 
vaccination campaigns, which averaged 41.1% from 2005-2008 (p=<0.001) and 46.8% in 
2010 (p=<0.001). Of note, in 2010 seasonal influenza vaccination in the community began 
earlier than usual and for the first time, 5% of those seen at the FDNY-BIOPOD were 
already vaccinated.
There was no difference in acceptance of the H1N1 vaccination by service (54.8% firefighter 
vs. 55.0% EMS, p=0.82) or by smoking status (54.9% ever smokers vs. 54.1% never 
smokers, p=0.49). H1N1 influenza vaccine acceptors were, on average, older (39.6±8.9 
years) compared to refusers (37.1±8.7; p=<0.03) and more likely to be male (55.5% males 
vs. 45.8% females, p=<0.0001). Among women, 55.9% of women under 40 accepted 
compared with 44.1% of those 40 and over (p=0.06).
In unadjusted and adjusted analyses (table 1), African Americans were about half as likely 
as others to accept H1N1 vaccination (AOR=0.46, CI95=0.4-0.5). Workers who accepted 
prior seasonal influenza vaccinations were significantly more likely to also accept the 2009 
H1N1 influenza vaccination in unadjusted (OR 4.5; CI95=4.2-4.9) and adjusted analyses 
(AOR=4.4, CI95=4.0-4.8). Workers who accepted multiple influenza vaccinations prior to 
the H1N1 vaccination campaign were also more likely to accept the 2009 H1N1 influenza 
vaccination. After adjusting for age, gender, race, service (firefighter or EMS), and smoking 
status, there was a 56% increased odds of accepting the H1N1 vaccination for each year of 
prior seasonal influenza vaccine acceptance.
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Significantly more workers were offered the 2009 H1N1 influenza vaccination during 
FDNY-BIOPOD than during BHS monitoring/treatment visits (9,559 vs. 1,053, p=<0.0001). 
More importantly, workers were more likely to accept vaccination offered during FDNY-
BIOPOD (AOR = 2.7, CI95= 2.3-3.2). Table 2 shows that accepting H1N1 vaccination 
during the FDNY-BIOPOD was more likely for those who had received prior seasonal 
influenza vaccinations (AOR = 4.2, CI95= 3.8-4.6) and for those who had received four or 
more seasonal influenza vaccinations (AOR = 9.97, CI95= 4.5-11.7). Rank had a significant 
effect, as officers were more likely to accept the H1N1 influenza vaccination during FDNY-
BIOPOD than non-officers (AOR = 1.9, CI95= 1.7-2.2).
FDNY workers with co-morbid respiratory diseases (n=506) were 40% more likely to accept 
H1N1 vaccination (AOR = 1.4, CI95 = 1.1-1.7) than those without such classification. There 
was no significant difference in ILI-related medical leave (incidence or duration) for the co-
morbid group and the rest of the cohort. However, the mean age of the co-morbid group 
(44.8 years) was significantly older than the rest of the cohort (38.2 years, p=<0.0001). In 
addition, the co-morbid group was more likely to be a firefighter (AOR=5.4, CI95 = 3.3-9.0), 
an officer (AOR=1.3, CI95 = 1.01-1.6), and more likely to have accepted prior influenza 
vaccinations (AOR=1.5, CI95 =1.2-1.9). For the entire cohort, a low FEV1 alone 
(≤80 %predicted) was not associated with increased rates of H1N1 vaccination after 
adjusting for age, gender, race, service (EMS or Fire), and smoking status (Table 3).
H1N1 vaccine acceptors were less likely to be absent for at least one day (7.8%) compared 
to refusers (9.3%, p=0.007) (table 4) due to a physician diagnosis of bronchitis, URI, or 
influenza. However, among those who took sick leave for ILI diagnoses (N=890), there was 
no difference in the average sick leave duration (8.6±5.4 days among acceptors vs. 8.1±5.3 
among refusers). When looking at medical leave by service, firefighters were more likely to 
take medical leave (10.3%) than EMS (1.7%, p=<0.0001). In addition, among all members 
who took at least one day of medical leave, firefighters took significantly more days 
(8.5±5.2) of medical leave than EMS (4.5±7.2, p=<0.0001).
Discussion
During the H1N1 outbreak and vaccination campaign, 77% of the active FDNY workforce 
was offered H1N1 vaccination. Of those offered H1N1 vaccination, the overall acceptance 
rate was 55%, but the difference between acceptance rates during routine BHS medical visits 
as compared with the FDNY-BIOPOD drill was striking: 34% vs. 57%. This highlights the 
differences between a relatively passive program with vaccine availability during any 
medical monitoring/treatment visit as compared to a dedicated campaign, which includes 
targeted education, and takes advantage of peer norms and social influence to improve 
vaccine acceptance. A prior study in HCWs of seasonal influenza vaccination found that 
sources of social influence differed between the vaccine acceptors and refusers. Those 
vaccinated were more likely to follow advice of others, in particular advice from 
supervisors, the public health department, the charge nurse, and physicians [22].
Since vaccination acceptance rates were substantially higher at the FDNY-BIOPOD, the 
“where” and “how” a vaccination program is administered has an important impact on 
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vaccine acceptance. FDNY-BIOPOD provides an opportunity for positive social influence 
and serves as an active demonstration of the commitment that leadership has made to the 
health and safety of its workforce. This is especially important in a workforce that often 
voices concern about transmission of work-related infections to co-workers, patients, and 
family members. With high vaccine acceptance and efficacy rates, influenza vaccination can 
prevent ILI not only in those vaccinated but throughout the wider population in which they 
serve [23].
Consistent with prior studies on seasonal influenza vaccination acceptance rates [9, 12], we 
found that receiving previous seasonal influenza vaccination(s) was associated with higher 
rates of H1N1 vaccination and was the single best predictor of H1N1 vaccine acceptance. 
Among HCWs, influenza vaccination acceptance has also been shown to increase rates of 
accepting hepatitis B vaccination [16], suggesting that people who accept influenza 
vaccination are more likely to accept other preventive forms of medicine. Based on these 
results, campaigns such as FDNY-BIOPOD to increase influenza vaccine acceptance rates 
may have far greater health impact than just reducing the incidence of ILI.
Our study found that officers were more likely to accept vaccination than non-officers. A 
prior study in non-FDNY EMS workers found that officers were more likely to accept 
Hepatitis B vaccination that non-officers [24]. In other studies, medical personnel employed 
longer were more likely to accept vaccination suggesting that training, seniority, and 
increasing age in addition to social influence can lead to increased rates of influenza 
vaccination acceptance [10]. This is consistent with our finding that vaccine acceptance 
increased with rank and with increasing age, as at FDNY, both are closely correlated with 
years of service. Officers were more likely to be vaccinated than non-officers throughout the 
entire H1N1 vaccination campaign suggesting that in the future vaccination programs should 
attempt to leverage the role of officers, leaders, and senior workers as role models to help 
increase acceptance rates.
This study also found that acceptance rates were significantly lower in African American 
FDNY workers. At FDNY, firefighters and EMS workers have the same training, vaccine 
education, and free access to FDNY-BIOPOD. Therefore, our finding is surprising, given 
that other studies have found lower rates of influenza vaccination among African Americans 
mostly attributed to socio-economic barriers [25]. We also found lower acceptance rates 
among workers under the age of 30, which is again surprising as younger cohorts were more 
affected by H1N1 [5]. These findings suggest the need for targeted and focused educational 
campaigns to improve acceptance by all affected groups.
In the current study, men were more likely to accept vaccination than women. We did not 
find previous research which either supports or refutes this finding. It is possible that 
younger women were more likely to accept vaccination than older ones because of concerns 
about the possibility of pregnancy in the younger cohort. Pregnant women were one of the 
original target groups for vaccination because pregnancy puts a woman at higher risk for 
H1N1 complications [5].
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Guidelines suggested H1N1 vaccination for those with chronic respiratory diseases because 
they were at higher risk for complications resulting from influenza [26]. Consistent with this 
recommendation, we found that FDNY workers with co-morbid respiratory diseases were 
more likely to accept H1N1 vaccination, confirming a successful educational campaign. In 
contrast, vaccine acceptance rates did not increase in workers with FEV1 % predicted below 
80%, perhaps because these workers do not realize that low or abnormal lung function is a 
sign of respiratory disease and an indication for influenza vaccination. Future vaccination 
campaigns should tailor the message of increased risk to a broader audience that in all 
likelihood would qualify based on abnormal pulmonary function measurements.
Because influenza is highly contagious and can cause serious illness, in 2009 the CDC 
recommended that people with ILI stay home and away from the public for at least 24 hours 
after the fever broke, which meant an average of three to five days sick leave [27]. FDNY 
did the same and issued department orders stating that all ILI sick leave in 2009 would be 
considered work-related for FDNY firefighters and EMS workers as long as it was reported 
to the FDNY-BHS. This allowed sick leave documentation in the FDNY electronic medical 
record to be as complete as possible. Prior studies in non-FDNY HCWs found that seasonal 
influenza vaccine acceptors were less likely to take sick leave than vaccine refusers, 
although there was no difference in the number of days taken [17]. This trend was the same 
in our population, where H1N1 vaccine acceptors were less likely to be absent for one or 
more days than refusers, although the duration of ILI-related sick leave was not different. 
However, firefighters were more likely to take sick leave and be absent for more days than 
EMS workers suggesting further education is needed on staying home with ILI. We do not 
believe absenteeism for these symptoms was related to non-H1N1 influenza, as other 
influenza strains were nearly nonexistent in NYC during this time-period [28].
At FDNY-BIOPOD, after providing education on safety, efficacy, and benefit, after 
removing cost and convenience barriers, and with full backing from labor/management 
leadership, an H1N1 vaccination acceptance rate of 57% was achieved. This is particularly 
noteworthy as the H1N1 vaccine was a new and unknown vaccination. This acceptance rate 
is arguably as high as any voluntary influenza vaccination program reported in the literature 
[9-11]. Nonetheless, it is far from the nearly 100% achieved by mandatory vaccination 
programs such as vaccination in the military [13-15]. Moreover, the rate of voluntary 
acceptance remained far lower than the 70% acceptance rate estimated by some [29, 30] as a 
requirement for achieving “herd” immunity – a rate high enough to prevent contagious 
disease even in non-vaccinated.
In a voluntary program, what else could be done to further improve vaccination rates? We 
did see higher rates of H1N1 vaccination acceptance during the 2009 FDNY-BIOPOD than 
in previous years. This suggests that increasing the number of FDNY-BIOPOD days to reach 
greater numbers in a socially persuasive and culturally acceptable environment coupled with 
improved educational messages tailored specifically to affected populations (HCWs, first 
responders) and minority populations could increase vaccination acceptance rates further. 
However, even with these additional efforts it is unlikely that rates in a voluntary program 
would be high enough to achieve herd immunity [29, 30]. And yet vaccination is an 
important component of HCW protection, especially for firefighters and EMS workers, who 
Glaser et al. Page 7
Vaccine. Author manuscript; available in PMC 2016 August 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
work in close quarters and assess and treat patients in poorly ventilated areas lacking the 
environmental controls found in most medical facilities and where the only barrier to 
contagion is their personal protective equipment (i.e., N95 respirator).
In summary, this study examines influenza vaccination behavior among an urban firefighter 
and EMS population. An active H1N1 vaccination campaign was able to reach over 75% of 
FDNY workers, obtaining a 55% vaccination acceptance rate. We found that prior seasonal 
influenza vaccination and offering vaccination in a group setting such as FDNY-BIOPOD 
increased H1N1 vaccine acceptance. These results can be used to design future vaccination 
campaigns at FDNY and elsewhere. In a workforce for whom vaccination is strongly 
recommended [5, 16], it is important that we continue to monitor vaccination behaviors and 
improve the proportion of HCWs, including pre-hospital HCWs (i.e. firefighters and EMS 
workers) offered and accepting vaccination.
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Table 1
Predictors of acceptance of the 2009 H1N1 influenza vaccination.
Unadjusted Adjusteda
n % Accept (n) % Accept by row OR 95% CI OR 95% CI
Total 10612 100.00 5831 54.95
Age
    <30 1928 18.17 842 43.67 0.70 0.62-0.78 0.66 0.59-0.75
    30-39 4071 38.36 2145 52.69 1.00 (ref) 1.00 (ref)
    >39 4613 43.47 2844 61.65 1.44 1.33-1.57 1.37 1.25-1.50
Gender
    Female 570 5.37 261 45.79 1.00 (ref) 1.00 (ref)
    Male 10042 94.63 5570 55.47 1.48 1.25-1.75 1.46 1.19-1.79
Race
    Caucasian 8538 80.46 4823 56.49 1.00 (ref) 1.00 (ref)
    African American 770 7.26 307 39.87 0.51 0.44-0.59 0.46 0.38-0.54
    Hispanic 1153 10.87 612 53.08 0.87 0.77-0.99 0.85 0.74-0.98
    Asian 142 1.34 83 58.45 1.08 0.77-1.52 1.06 0.74-1.53
    Native American 9 0.08 6 66.67 1.54 0.39-6.16 1.21 0.29-5.09
Class
    EMS 2254 21.24 1234 54.75 1.00 (ref) 1.00 (ref)
    Firefighter 8358 78.76 4597 55.00 1.01 0.92-1.11 0.70 0.61-0.79
Rank
    Officer 2289 21.57 1619 70.73 2.36 2.14-2.61 1.93 1.72-2.17
    Not an Officer 8323 78.43 4212 50.61 1.00 (ref) 1.00 (ref)
Smoking status (e/n)
    Ever 3251 35.18 1784 54.88 1.00 (ref) 1.00 (ref)
    Never 6989 64.82 3242 54.13 0.97 0.89-1.06 1.01 0.93-1.11
Vaccination at FDNY-BIOPOD
    No 1053 9.92 362 34.38 1.00 (ref) 1.00 (ref)
    Yes 9559 90.08 5469 57.21 2.55 2.23-2.92 2.72 2.34-3.15
Prior Seasonal Influenza Vaccination
    No 4347 39.22 1467 33.75 1.00 (ref) 1.00 (ref)
    Yes 6268 60.78 4364 69.66 4.51 4.15-4.90 4.35 3.97-4.77
Number of Prior Influenza Vaccinations
    0 2873 31.44 835 29.06 1.00 (ref) 1.00 (ref)
    1 to 3 4226 46.25 2650 62.71 3.30 3.02-3.61 3.36 3.05-3.70
    4 or more 2039 22.31 1714 84.06 10.35 9.05-11.84 10.75 9.23-12.54
OR = Odds Ratio; (Ref) = Reference Group
a
Each variable is adjusted for age, gender, race, class, and smoking status
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Table 2
Predictors of acceptance of 2009 H1N1 influenza vaccination during FDNY-BIOPOD.
Unadjusted Adjusteda
N % Accept (n) % Accept by row OR 95% CI OR 95% CI
Total 9559 100.00 5469 57.21
Class
    EMS 2053 21.48 1175 57.23 1.00 (ref) 1.00 (ref)
    Firefighter 7506 78.52 4294 57.21 1.00 0.91-1.10 0.69 0.60-0.78
Rank
    Officer 2051 21.46 1490 72.65 2.36 2.12-2.62 1.94 1.71-2.20
    Not an officer 7508 78.54 3979 53.00 1.00 (ref) 1.00 (ref)
Prior Seasonal Influenza Vaccination
    No 3889 40.68 1423 36.59 1.00 (ref) 1.00 (ref)
    Yes 5670 59.32 4046 71.36 4.32 3.96-4.71 4.17 3.79-4.59
Number of Prior Influenza Vaccinations
    0 2474 30.38 804 32.50 1.00 (ref) 1.00 (ref)
    1 to 3 3813 46.82 2470 64.78 3.19 2.90-3.50 3.25 2.94-3.59
    4 or more 1857 22.80 1576 84.87 9.72 8.43-11.21 9.97 4.48-11.72
OR = Odds Ratio; (Ref) = Reference Group
a
Each variable is adjusted for age, gender, race, class, and smoking status
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Table 3
Predictors of 2009 H1N1 vaccination acceptance.
Unadjusted Adjusteda
N % Accept (n) % Accepted by row OR 95% CI OR 95% CI
FEV1 % predicted
    ≤80 1234 11.63 725 58.75 1.19 1.06-1.34 1.06 0.93-1.22
    >80 9378 88.37 5106 54.45 1.00 (ref) 1.00 (ref)
Respiratory Disease
    Yes 506 4.77 340 67.19 1.72 1.42-2.08 1.4 1.14-1.73
    No 10106 95.23 5491 54.33 1.00 (ref) 1.00 (ref)
OR = Odds Ratio; (Ref) = Reference Group
a
Each variable is adjusted for age, gender, race, class, and smoking status
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Table 4
Medical leave for vaccine acceptors and vaccine refusers.
Vaccine acceptors Vaccine refusers p
N 5790 4757
Number who took 1 or more sick days 450 440
Percent 7.77 9.25 0.0066
Mean days (SD)
    At least one day 8.60 (5.42) 8.13 (5.25) 0.18
    Entire population 0.67 (2.75) 0.75 (2.84) 0.13
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